Specialization of tumour vasculature
Top Cited Papers
- 1 February 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (2), 83-90
- https://doi.org/10.1038/nrc724
Abstract
Tumour blood vessels express markers that are not present in resting blood vessels of normal tissues, but that can be shared by angiogenic vessels in non-malignant conditions. Many of these proteins are functionally important in the angiogenic process. Some tumours also contain lymphatic vessels, as well as channels that consist of cancer cells and their extracellular matrix. These special features of tumour vessels are good targets for cancer therapies.Keywords
This publication has 63 references indexed in Scilit:
- LYVE-1, the lymphatic system and tumor lymphangiogenesisTrends in Immunology, 2001
- Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing bloodProceedings of the National Academy of Sciences, 2000
- Targeting tumor vasculature with homing peptides from phage displaySeminars in Cancer Biology, 2000
- Vasculogenic Mimicry and Tumor AngiogenesisThe American Journal of Pathology, 2000
- Vasculogenic Mimicry: How Convincing, How Novel, and How Significant?The American Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000
- Clinical applications of angiogenic growth factors and their inhibitorsNature Medicine, 1999
- Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic MimicryThe American Journal of Pathology, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996